Vitiligo
222
23
35
91
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
22 trials with published results (10%)
Research Maturity
91 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
14 terminated out of 222 trials
86.7%
+0.2% vs benchmark
14%
30 trials in Phase 3/4
24%
22 of 91 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 91 completed trials
Clinical Trials (222)
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo
Vitiligo Registry for Adults and Children in the UK
Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo
Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO
Atorvastatin in Active Vitiligo
Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
Translational Assessment of Vitiligo According to Body Locations
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo.
Daily Topical Rapamycin for Vitiligo
The Value of Methotrexate in NCES for Stable Vitiligo
Oral Mini Pulse Dexamethasone in Pediatric Vitiligo
Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo
In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases
A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial
Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo